Skip to main content

Advertisement

Log in

Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Multiple sclerosis (MS) is an autoimmune/inflammatory neurodegenerative disease which mainly affects the central nervous system in young adults. Fc-receptor-like-3 (FCRL3) gene, which involved in immune cell regulation, has drawn lots of attentions. This study aims to investigate the association between common polymorphisms of FCRL3 gene and MS risk in a Chinese Han population. Nine single nucleotide polymorphisms (SNPs) were genotyped in 120 patients and 240 healthy controls through PCR assay. t test and chi-square test was conducted to find a possible association between FCRL3 genetic mutations and risk of MS. This analysis results performed that four SNPs, rs7528684 (FCRL3_3), rs945635 (FCRL3_5), rs3761959 (FCRL3_6), and rs2282284 (FCRL3_8), were significantly associated with the risk of MS. Further haplotype analysis showed two haplotypes of FCRL3_3, 5, 6, 8, CCAG and CGAG, presented the significant associations with the susceptibility to MS. Four SNPs in FCRL3 gene could possibly associate with the susceptibility of MS in a Chinese Han population. Moreover, the haplotype analysis confirmed that the linkage disequilibrium exists in polymorphisms in FCRL3. Based on the supporting evidence, we deduced that FCRL3_3C, FCRL3_5C, FCRL3_6A, and FCRL3_8G caused increased risk of MS. Nevertheless, large cohort studies are required in the future to validate the autoimmune function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Martinez A, Mas A, de Las Heras V, Bartolome M, Arroyo R, Fernandez-Arquero M, de la Concha EG, Urcelay E (2007) FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity? J Neuroimmunol 189(1–2):132–136. doi:10.1016/j.jneuroim.2007.06.018

    Article  CAS  PubMed  Google Scholar 

  2. Matesanz F, Fernandez O, Milne RL, Fedetz M, Leyva L, Guerrero M, Delgado C, Lucas M et al (2008) The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J Neuroimmunol 195(1–2):146–150. doi:10.1016/j.jneuroim.2008.01.004

    Article  CAS  PubMed  Google Scholar 

  3. Dyment DA, Ebers GC, Dessa Sadovnick A (2004) Genetics of multiple sclerosis. Lancet Neurol 3(2):104–110

    Article  CAS  PubMed  Google Scholar 

  4. Fedetz M, Matesanz F, Caro‐Maldonado A, Fernandez O, Tamayo J, Guerrero M, Delgado C, López Guerrero J et al (2006) OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68(5):446–449

    Article  CAS  PubMed  Google Scholar 

  5. Leyva L, Fernández O, Fedetz M, Blanco E, Fernández VE, Oliver B, León A, Pinto-Medel M-J et al (2005) IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. J Neuroimmunol 163(1):165–171

    Article  CAS  PubMed  Google Scholar 

  6. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S et al (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37(5):478–485. doi:10.1038/ng1540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, de Ramon E, Garcia-Hernandez FJ, Koeleman B et al (2006) Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45(8):1044–1046. doi:10.1093/rheumatology/kel160

    Article  CAS  Google Scholar 

  8. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC (2006) Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin Endocr Metab 91(3):1056–1061. doi:10.1210/jc.2005-1634

    Article  CAS  PubMed  Google Scholar 

  9. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW (2007) FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 66(6):803–806. doi:10.1136/ard.2006.064949

    Article  CAS  PubMed  Google Scholar 

  10. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S (2006) Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 55(9):1367–1368. doi:10.1136/gut.2006.095059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Capon F, Semprini S, Chimenti S, Fabrizi G, Zambruno G, Murgia S, Carcassi C, Fazio M et al (2001) Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol 116(5):728–730. doi:10.1046/j.1523-1747.2001.01311.x

    Article  CAS  PubMed  Google Scholar 

  12. Dai KZ, Harbo HF, Celius EG, Oturai A, Sorensen PS, Ryder LP, Datta P, Svejgaard A et al (2001) The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Gen Immun 2(5):263–268. doi:10.1038/sj.gene.6363774

    Article  CAS  Google Scholar 

  13. Chistiakov DA, Chistiakov AP (2007) Is FCRL3 a new general autoimmunity gene? Hum Immunol 68(5):375–383. doi:10.1016/j.humimm.2007.01.013

    Article  CAS  PubMed  Google Scholar 

  14. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275–290. doi:10.1146/annurev.immunol.19.1.275

    Article  CAS  PubMed  Google Scholar 

  15. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR (2007) Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocr Metab 92(3):1106–1111. doi:10.1210/jc.2006-2183

    Article  CAS  PubMed  Google Scholar 

  16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227–231. doi:10.1002/ana.410130302

    Article  CAS  PubMed  Google Scholar 

  17. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265. doi:10.1093/bioinformatics/bth457

    Article  CAS  PubMed  Google Scholar 

  18. Eyre S, Bowes J, Potter C, Worthington J, Barton A (2006) Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity? Arthritis Res Therapy 8(4):R117. doi:10.1186/ar2006

    Article  Google Scholar 

  19. Begovich AB, Chang M, Schrodi SJ (2007) Meta-analysis evidence of a differential risk of the FCRL3–169 T– > C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 56(9):3168–3171. doi:10.1002/art.22857

    Article  CAS  PubMed  Google Scholar 

  20. Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C (2008) FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits. Biomed Pharmacother 62(3):153–157. doi:10.1016/j.biopha.2007.09.003

    Article  CAS  PubMed  Google Scholar 

  21. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, Kamatani N (2006) Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 65(5):671–673. doi:10.1136/ard.2005.043489

    Article  CAS  PubMed  Google Scholar 

  22. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J, Johnson B, Greer W et al (2006) Rheumatoid arthritis association with the FCRL3–169C polymorphism is restricted to PTPN22 1858 T-homozygous individuals in a Canadian population. Arthritis Rheum 54(12):3820–3827. doi:10.1002/art.22270

    Article  CAS  PubMed  Google Scholar 

  23. Martinez A, Sanchez E, Valdivia A, Orozco G, Lopez-Nevot MA, Pascual-Salcedo D, Balsa A, Fernandez-Gutierrez B et al (2006) Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1188–1191. doi:10.1136/ard.2005.048454

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hu X, Chang M, Saiki RK, Cargill MA, Begovich AB, Ardlie KG, Criswell LA, Seldin MF et al (2006) The functional − 169 T → C single‐nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 54(3):1022–1025

    Article  PubMed  Google Scholar 

  25. Turunen JA, Wessman M, Kilpikari R, Parkkonen M, Forsblom C, Groop PH (2006) The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to Type 1 diabetes. Diabet Med 23(8):925–927. doi:10.1111/j.1464-5491.2006.01848.x

    Article  CAS  PubMed  Google Scholar 

  26. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD et al (2006) Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Gen 7:20. doi:10.1186/1471-2350-7-20

    Article  Google Scholar 

  27. Zhao SX, Liu W, Zhan M, Song ZY, Yang SY, Xue LQ, Pan CM, Gu ZH et al (2013) A refined study of FCRL genes from a genome-wide association study for Graves’ disease. PLoS One 8(3):e57758. doi:10.1371/journal.pone.0057758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zheng R, Zhao Z, Zhang S, Li R (2009) Study on the association of 3 SNPs of FcRL3 gene with Graves disease in Chongqing Han population. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chin J Med Gen 26(6):681–685. doi:10.3760/cma.j.issn. 1003-9406.2009.06.016

    CAS  Google Scholar 

  29. Li K, Zhao M, Hou S, Du L, Kijlstra A, Yang P (2008) Association between polymorphisms of FCRL3, a non-HLA gene, and Behcet’s disease in a Chinese population with ophthalmic manifestations. Mol Vis 14:2136–2142

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Ehrhardt GR, Leu CM, Zhang S, Aksu G, Jackson T, Haga C, Hsu JT, Schreeder DM et al (2007) Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv Exp Med Biol 596:155–162. doi:10.1007/0-387-46530-8_14

    Article  PubMed  Google Scholar 

  31. Swainson LA, Mold JE, Bajpai UD, McCune JM (2010) Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 184(7):3639–3647. doi:10.4049/jimmunol.0903943

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Steinman L, Zamvil S (2003) Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol 3(6):483–492. doi:10.1038/nri1108

    Article  CAS  PubMed  Google Scholar 

  33. Steinman L (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 9(6):440–447. doi:10.1038/nri2548

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Longxiao Wei.

Additional information

Menghui Yuan and Longxiao Wei contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, M., Wei, L., Zhou, R. et al. Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study. Mol Neurobiol 53, 2029–2035 (2016). https://doi.org/10.1007/s12035-015-9149-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9149-7

Keywords

Navigation